| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.082 | 0.006 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.007 |